<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02908828</url>
  </required_header>
  <id_info>
    <org_study_id>2015/2303</org_study_id>
    <nct_id>NCT02908828</nct_id>
  </id_info>
  <brief_title>Calanus Oil Supplementation and Maximal Oxygen Uptake</brief_title>
  <official_title>Effect of Copepod Oil Supplementation (Calanus Finmarchicus) on Endurance and VO2max in Healthy Obese Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Tromso</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Calanus AS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Copepod oil is extracted from the marine copepod Calanus finmarchicus, the dominant plankton
      species in the marine food web in the Norwegian Sea. Copepods constitute the largest
      renewable and harvestable resource in the Norwegian Sea and adjacent waters, and it is now
      developed knowledge and technology for sustainable harvesting of this &quot;new&quot; resource. The
      purpose of this study is to investigate whether Calanus copepod oil supplementation has an
      equivalent effect on maximal oxygen uptake in humans to that seen in experimental studies in
      mice.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2016</start_date>
  <completion_date type="Actual">September 19, 2017</completion_date>
  <primary_completion_date type="Actual">September 19, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>maximal oxygen uptake (VO2max)</measure>
    <time_frame>6 months</time_frame>
    <description>Measured with indirect calorimetry at a treadmill (running/walking) with gradually increasing work load until exhaustion. After 10-15 min with warmup at 70% of maximal heart rate, work load will be increased every 1-2 minute and the changes maximal oxygen uptake (VO2) will be recorded automatically.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body composition (InBody, Japan)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported physical activity</measure>
    <time_frame>6 months</time_frame>
    <description>assessed with International Physical Activity Questionnaire (IPAQ) short version</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">71</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Calanus oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4 capsules of 500 mg Calanus oil once every day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>4 capsules of 500 mg dietary oil once every day</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Calanus oil</intervention_name>
    <arm_group_label>Calanus oil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo dietary oil</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  in good health

          -  Body mass index (BMI) between 18,5 and 29,9

        Exclusion Criteria:

          -  Medical condition limiting VO2max (COPD or asthma).

          -  diagnosed coronary artery disease

          -  Any other significant medical condition

          -  medication effecting exercise capacity (e.i. betablockers)

          -  Pregnancy

          -  Participation in other clinical trials

          -  Shellfish allergies

          -  Systolic blood pressure &gt; 170 mmHG, or diastolic BP &gt; 105 mmHG.

          -  contraindications for maximal exercise testing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulrik Wisløff, phd prof</last_name>
    <role>Study Director</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institutt for Medisinsk Biologi, UiT Norges arktiske universitet</name>
      <address>
        <city>Tromsø</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KG Jebsen-senter for Hjertetrening, NTNU</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2016</study_first_submitted>
  <study_first_submitted_qc>September 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2016</study_first_posted>
  <last_update_submitted>September 19, 2017</last_update_submitted>
  <last_update_submitted_qc>September 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Biological Products/therapeutic use</keyword>
  <keyword>Copepoda</keyword>
  <keyword>Dietary Supplements</keyword>
  <keyword>Fish Oils</keyword>
  <keyword>Fatty Acids, Omega-3</keyword>
  <keyword>Oxygen Consumption</keyword>
  <keyword>Calanus</keyword>
  <keyword>Maximal oxygen uptake</keyword>
  <keyword>Zooplankton</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

